Evelyn Ullrich

Novel immune modulators used in hematology: impact on NK cells.

The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.

A novel dendritic cell subset involved in tumor immunosurveillance.

[A new dendritic cell implicated in antitumoral immunity].

Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells.

Interferon-gamma is produced by another player of innate immune responses: the interferon-producing killer dendritic cell (IKDC).

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Ecto-calreticulin in immunogenic chemotherapy.

Dendritic cells and innate defense against tumor cells.

IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo.

Natural killer cell-directed therapies: moving from unexpected results to successful strategies.

The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2.

[IKDC: killer dendritic cells or antigen-presenting NK cells?].

Trans-presentation of IL-15 dictates IFN-producing killer dendritic cells effector functions.

Killer dendritic cells: IKDC and the others.

Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer.

The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.

Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany.

IL-18 induces PD-1-dependent immunosuppression in cancer.

Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo.

Antigen-specific transfer of functional programmed death ligand 1 from human APCs onto CD8+ T cells via trogocytosis.

Advances in cellular therapy: 6th International Symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany.

Influence of NK cell magnetic bead isolation methods on phenotype and function of murine NK cells.

Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells.

Immunoregulatory natural killer cells suppress autoimmunity by down-regulating antigen-specific CD8+ T cells in mice.

Tuberculous and non-tuberculous granulomatous lymphadenitis in patients receiving imatinib mesylate (glivec) for metastatic gastrointestinal stromal tumor.

Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol.

New prospects on the NKG2D/NKG2DL system for oncology.

Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion.

Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects.

NK Cell Subgroups, Phenotype, and Functions After Autologous Stem Cell Transplantation.

Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.

Selection and expansion of natural killer cells for NK cell-based immunotherapy.

Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.

Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.

Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.

The dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermia.

LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.